These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21674037)

  • 1. Role of ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs) and Runx2 and PPARγ2 expression in MSCs-like of osteoporotic patients.
    Valenti MT; Garbin U; Pasini A; Zanatta M; Stranieri C; Manfro S; Zucal C; Dalle Carbonare L
    PLoS One; 2011; 6(6):e20363. PubMed ID: 21674037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel PPARγ2 modulator sLZIP controls the balance between adipogenesis and osteogenesis during mesenchymal stem cell differentiation.
    Kim J; Ko J
    Cell Death Differ; 2014 Oct; 21(10):1642-55. PubMed ID: 24948012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression.
    Zhang L; Su P; Xu C; Chen C; Liang A; Du K; Peng Y; Huang D
    J Pineal Res; 2010 Nov; 49(4):364-72. PubMed ID: 20738756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis.
    You L; Pan L; Chen L; Gu W; Chen J
    Cell Physiol Biochem; 2016; 39(1):253-65. PubMed ID: 27337099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells.
    Kang Q; Song WX; Luo Q; Tang N; Luo J; Luo X; Chen J; Bi Y; He BC; Park JK; Jiang W; Tang Y; Huang J; Su Y; Zhu GH; He Y; Yin H; Hu Z; Wang Y; Chen L; Zuo GW; Pan X; Shen J; Vokes T; Reid RR; Haydon RC; Luu HH; He TC
    Stem Cells Dev; 2009 May; 18(4):545-59. PubMed ID: 18616389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N- and C-terminal domains of parathyroid hormone-related protein affect differently the osteogenic and adipogenic potential of human mesenchymal stem cells.
    Casado-Diaz A; Santiago-Mora R; Quesada JM
    Exp Mol Med; 2010 Feb; 42(2):87-98. PubMed ID: 19946180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ).
    Zhang W; Yang N; Shi XM
    J Biol Chem; 2008 Feb; 283(8):4723-9. PubMed ID: 18084007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of small interfering ribonucleic acids to inhibit the adipogenic effect of alcohol on human bone marrow-derived mesenchymal cells.
    Huang Q; Zhang H; Pei FX; Chen ZY; Wang GL; Shen B; Yang J; Zhou ZK; Kong QQ
    Int Orthop; 2010 Oct; 34(7):1059-68. PubMed ID: 19960194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action.
    Astudillo P; Ríos S; Pastenes L; Pino AM; Rodríguez JP
    J Cell Biochem; 2008 Mar; 103(4):1054-65. PubMed ID: 17973271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures.
    Li X; Cui Q; Kao C; Wang GJ; Balian G
    Bone; 2003 Oct; 33(4):652-9. PubMed ID: 14555271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue.
    Xu L; Liu Y; Sun Y; Wang B; Xiong Y; Lin W; Wei Q; Wang H; He W; Wang B; Li G
    Stem Cell Res Ther; 2017 Dec; 8(1):275. PubMed ID: 29208029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner.
    Wagegg M; Gaber T; Lohanatha FL; Hahne M; Strehl C; Fangradt M; Tran CL; Schönbeck K; Hoff P; Ode A; Perka C; Duda GN; Buttgereit F
    PLoS One; 2012; 7(9):e46483. PubMed ID: 23029528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone.
    Bruedigam C; Eijken M; Koedam M; van de Peppel J; Drabek K; Chiba H; van Leeuwen JP
    Stem Cells; 2010 May; 28(5):916-27. PubMed ID: 20213769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could the effect of modeled microgravity on osteogenic differentiation of human mesenchymal stem cells be reversed by regulation of signaling pathways?
    Zheng Q; Huang G; Yang J; Xu Y; Guo C; Xi Y; Pan Z; Wang J
    Biol Chem; 2007 Jul; 388(7):755-63. PubMed ID: 17570829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel semisynthetic molecule icaritin stimulates osteogenic differentiation and inhibits adipogenesis of mesenchymal stem cells.
    Sheng H; Rui XF; Sheng CJ; Li WJ; Cheng XY; Jhummon NP; Yu YC; Qu S; Zhang G; Qin L
    Int J Med Sci; 2013; 10(6):782-9. PubMed ID: 23630444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A16 inhibits osteogenesis but stimulates adipogenesis.
    Li D; Zhang R; Zhu W; Xue Y; Zhang Y; Huang Q; Liu M; Liu Y
    Mol Biol Rep; 2013 May; 40(5):3465-73. PubMed ID: 23526364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myricetin 3-
    Karadeniz F; Oh JH; Jo HJ; Seo Y; Kong CS
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoids of Herba Epimedii stimulate osteogenic differentiation and suppress adipogenic differentiation of primary mesenchymal stem cells via estrogen receptor pathway.
    Zhang D; Liu L; Jia Z; Yao X; Yang M
    Pharm Biol; 2016; 54(6):954-63. PubMed ID: 26453492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylation.
    Shakibaei M; Shayan P; Busch F; Aldinger C; Buhrmann C; Lueders C; Mobasheri A
    PLoS One; 2012; 7(4):e35712. PubMed ID: 22539994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis.
    Dalle Carbonare L; Valenti MT; Zanatta M; Donatelli L; Lo Cascio V
    Arthritis Rheum; 2009 Nov; 60(11):3356-65. PubMed ID: 19877060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.